MIDAS: rapid, multiplexed molecular profiling for integrated host-pathogen analysis

Area of Science:

• Biotechnology
• Infectious Disease Diagnostics
• Bioanalytical Chemistry

Background:

• Integrated molecular analysis is crucial for complex infectious diseases, but current tools often analyze pathogens or host responses separately.
• Sepsis research specifically needs rapid methods to quantify both microbial and host biomarkers for effective diagnosis and treatment.
• Existing diagnostic workflows, such as microbial culture, are time-consuming, delaying critical clinical decisions.

Purpose of the Study:

• To develop and present MIDAS (Multiplexed Intelligent Diffraction Analysis System), a novel platform for simultaneous host-pathogen molecular profiling.
• To demonstrate the potential of MIDAS for rapid, integrated analysis in infectious conditions, particularly sepsis.
• To evaluate the feasibility of MIDAS for potential point-of-care applications.

Main Methods:

• Integration of shape-encoded hydrogel particles with lens-free diffraction imaging.
• Application of deep learning algorithms for data analysis.
• Simultaneous quantification of bacterial RNA and inflammatory proteins within a single assay system.

Main Results:

• The MIDAS assay achieved multiplexed measurements in under 4 hours, significantly faster than traditional culture methods (20-40 hours).
• High concordance was observed between MIDAS results and established methods (culture, qPCR, ELISA) in a porcine sepsis model.
• The platform demonstrated successful simultaneous quantification of both bacterial RNA and host inflammatory proteins.

Conclusions:

• MIDAS represents a proof-of-concept for a flexible, integrated host-pathogen profiling platform.
• The system's speed and multiplexing capabilities offer a significant advancement over current diagnostic workflows.
• Further clinical validation is needed, but MIDAS shows promise for accessible diagnostic tools in healthcare, agriculture, and food safety.